Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats
- PMID: 15659302
- DOI: 10.1016/j.ejphar.2004.11.055
Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats
Abstract
Sensori-motor gating, as assessed by prepulse inhibition of the startle response is diminished in patients with schizophrenia. We have previously shown that inbred Brown Norway (BN) rats display significantly less prepulse inhibition of the acoustic startle response than inbred Wistar-Kyoto (WKY) rats, and that prepulse inhibition is decreased by central administration of the neuropeptide, corticotropin-releasing factor (CRF) in both strains. The present study was conducted to establish whether peripheral administration of CRF alters prepulse inhibition, whether a low, threshold dose for decreasing prepulse inhibition is the same in the two rat strains, and whether central administration of a CRF receptor antagonist enhances prepulse inhibition in the BN strain. CRF-induced behavioral activation was also examined to determine whether the two rat strains are differentially sensitive to a behavioral effect of CRF that does not involve the startle response. In each experiment, BN rats showed significantly less prepulse inhibition than WKY rats. Subcutaneous administration of CRF had no affect on startle amplitude or prepulse inhibition of the startle response in either rat strain. In BN, but not in WKY rats, low-dose CRF (0.3 microg) decreased prepulse inhibition. However, doses of CRF that did not alter prepulse inhibition in the WKY strain, did result in behavioral activation. No dose of CRF tested affected baseline startle amplitude. Central administration of the CRF receptor antagonist, astressin had no effect on prepulse inhibition or startle amplitude in either rat strain. Central administration of the CRF receptor antagonist, D-Phe CRF (12-41) had no effect on prepulse inhibition in WKY rats, resulted in a only a small, non-significant increase in prepulse inhibition in BN rats, while it decreased startle amplitude. The results suggest that CRF reduces prepulse inhibition of the acoustic startle response independently of effects on the pituitary-adrenal axis, and that endogenous CRF has at most, a minor role in the low prepulse inhibition found in BN rats.
Similar articles
-
Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.Neuropharmacology. 2012 Jan;62(1):256-63. doi: 10.1016/j.neuropharm.2011.07.016. Epub 2011 Aug 2. Neuropharmacology. 2012. PMID: 21835187 Free PMC article.
-
Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.Psychopharmacology (Berl). 2002 May;161(3):296-303. doi: 10.1007/s00213-002-1025-2. Epub 2002 Mar 28. Psychopharmacology (Berl). 2002. PMID: 12021833
-
Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain.Behav Neurosci. 2005 Aug;119(4):1052-60. doi: 10.1037/0735-7044.119.4.1052. Behav Neurosci. 2005. PMID: 16187833
-
Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor.Pharmacol Biochem Behav. 2006 Sep;85(1):261-72. doi: 10.1016/j.pbb.2006.08.009. Epub 2006 Sep 20. Pharmacol Biochem Behav. 2006. PMID: 16996121
-
Prepulse inhibition of acoustic startle in spontaneously hypertensive rats.Behav Brain Res. 2004 Oct 5;154(2):331-7. doi: 10.1016/j.bbr.2004.02.021. Behav Brain Res. 2004. PMID: 15313020
Cited by
-
Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.Neuropsychopharmacology. 2014 Oct;39(11):2633-45. doi: 10.1038/npp.2014.117. Epub 2014 May 23. Neuropsychopharmacology. 2014. PMID: 24853772 Free PMC article.
-
Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.Horm Behav. 2006 Nov;50(4):550-61. doi: 10.1016/j.yhbeh.2006.06.019. Epub 2006 Jul 25. Horm Behav. 2006. PMID: 16870185 Free PMC article. Review.
-
The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.Pharmacol Biochem Behav. 2010 Dec;97(2):227-38. doi: 10.1016/j.pbb.2010.08.003. Epub 2010 Aug 13. Pharmacol Biochem Behav. 2010. PMID: 20709096 Free PMC article.
-
Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.Neuropharmacology. 2012 Jan;62(1):256-63. doi: 10.1016/j.neuropharm.2011.07.016. Epub 2011 Aug 2. Neuropharmacology. 2012. PMID: 21835187 Free PMC article.
-
CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.Psychopharmacology (Berl). 2014 Apr;231(7):1289-303. doi: 10.1007/s00213-013-3315-2. Epub 2013 Nov 2. Psychopharmacology (Berl). 2014. PMID: 24186076
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources